ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human Transforming Growth Factor-β Market Research Report 2026
Published Date: 2026-01-26
|
Report Code: QYRE-Auto-12Z18613
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Human Transforming Growth Factor β Market Research Report 2024
BUY CHAPTERS

Global Recombinant Human Transforming Growth Factor-β Market Research Report 2026

Code: QYRE-Auto-12Z18613
Report
2026-01-26
Pages:142
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Thermo Fisher
Abcam
Atlantis Bioscience
Sigma-aldrich
MedChemexpress LLC
Miltenyi Biotec
Bio-Techne
Proteintech
Cell Guidance Systems
Cell Signaling Technology
Qkine
ACROBiosystems
FUJIFILM Irvine Scientific
Beijing Sino Biological
Abbkine Scientific
Yeasen Biotechnology (Shanghai)
Shanghai Zhong Qiao Xin Zhou Biotechnology
Nanjing Okay Biotechnology
Cellverse
Beijing T&L Biotechnology
EIAAB SCIENCE
Croyez Bioscience
Dalian Meilun Biotechnology
Suzhou Novoprotein Scientific
Shanghai DiLab Biotechnology
Beijing T&L Biotechnology

Recombinant Human Transforming Growth Factor-β Market Size

The global Recombinant Human Transforming Growth Factor-β market was valued at US$ 1740 million in 2025 and is anticipated to reach US$ 2758 million by 2032, at a CAGR of 6.9% from 2026 to 2032.

Recombinant Human Transforming Growth Factor-β Market

Recombinant Human Transforming Growth Factor-β Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Recombinant Human Transforming Growth Factor-β competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Recombinant human transforming growth factor-β is a biologically active protein produced by genetic engineering technology. It simulates the function of transforming growth factor-β naturally present in the human body and participates in regulating biological processes such as cell proliferation, differentiation and immune response. It is characterized by high specificity and activity, which can effectively promote cell growth and tissue repair; it has strong controllability during the production process and can be prepared on a large scale to meet clinical and scientific research needs; at the same time, due to its recombinant nature, it avoids the potential risks of animal-derived products. The advantage is that rh-TGF-β provides a new biological drug for clinical treatment, which is used to promote wound healing, treat inflammation and certain diseases, and has important medical value and broad application prospects.
The North American market for Recombinant Human Transforming Growth Factor-β is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Recombinant Human Transforming Growth Factor-β is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Recombinant Human Transforming Growth Factor-β include Thermo Fisher, Abcam, Atlantis Bioscience, Sigma-Aldrich, MedChemExpress, Miltenyi Biotec, Bio-Techne, Proteintech, Cell Guidance Systems, Cell Signaling Technology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Recombinant Human Transforming Growth Factor-β market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Recombinant Human Transforming Growth Factor-β. The Recombinant Human Transforming Growth Factor-β market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Recombinant Human Transforming Growth Factor-β market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Recombinant Human Transforming Growth Factor-β manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Recombinant Human Transforming Growth Factor-β Market Report

Report Metric Details
Report Name Recombinant Human Transforming Growth Factor-β Market
Accounted market size in 2025 US$ 1740 million
Forecasted market size in 2032 US$ 2758 million
CAGR 6.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • TGF-β1
  • TGF-β2
  • TGF-β3
by Application
  • Hospital
  • Research Institute
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher, Abcam, Atlantis Bioscience, Sigma-Aldrich, MedChemExpress, Miltenyi Biotec, Bio-Techne, Proteintech, Cell Guidance Systems, Cell Signaling Technology, Qkine, ACROBiosystems, FUJIFILM Irvine Scientific, Croyez Bioscience, Beijing Sino Biological, Abbkine Scientific, Yeasen Biotechnology (Shanghai), Dalian Meilun Biotechnology, Shanghai Zhong Qiao Xin Zhou Biotechnology, Suzhou Novoprotein Scientific, Nanjing Okay Biotechnology, Cellverse, Beijing T&L Biotechnology, EIAAB SCIENCE, Shanghai DiLab Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Recombinant Human Transforming Growth Factor-β manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Recombinant Human Transforming Growth Factor-β sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Recombinant Human Transforming Growth Factor-β Market growing?

Ans: The Recombinant Human Transforming Growth Factor-β Market witnessing a CAGR of 6.9% during the forecast period 2026-2032.

What is the Recombinant Human Transforming Growth Factor-β Market size in 2032?

Ans: The Recombinant Human Transforming Growth Factor-β Market size in 2032 will be US$ 2758 million.

Who are the main players in the Recombinant Human Transforming Growth Factor-β Market report?

Ans: The main players in the Recombinant Human Transforming Growth Factor-β Market are Thermo Fisher, Abcam, Atlantis Bioscience, Sigma-Aldrich, MedChemExpress, Miltenyi Biotec, Bio-Techne, Proteintech, Cell Guidance Systems, Cell Signaling Technology, Qkine, ACROBiosystems, FUJIFILM Irvine Scientific, Croyez Bioscience, Beijing Sino Biological, Abbkine Scientific, Yeasen Biotechnology (Shanghai), Dalian Meilun Biotechnology, Shanghai Zhong Qiao Xin Zhou Biotechnology, Suzhou Novoprotein Scientific, Nanjing Okay Biotechnology, Cellverse, Beijing T&L Biotechnology, EIAAB SCIENCE, Shanghai DiLab Biotechnology

What are the Application segmentation covered in the Recombinant Human Transforming Growth Factor-β Market report?

Ans: The Applications covered in the Recombinant Human Transforming Growth Factor-β Market report are Hospital, Research Institute, Others

What are the Type segmentation covered in the Recombinant Human Transforming Growth Factor-β Market report?

Ans: The Types covered in the Recombinant Human Transforming Growth Factor-β Market report are TGF-β1, TGF-β2, TGF-β3

1 Recombinant Human Transforming Growth Factor-β Market Overview
1.1 Product Definition
1.2 Recombinant Human Transforming Growth Factor-β by Type
1.2.1 Global Recombinant Human Transforming Growth Factor-β Market Value by Type: 2025 vs 2032
1.2.2 TGF-β1
1.2.3 TGF-β2
1.2.4 TGF-β3
1.3 Recombinant Human Transforming Growth Factor-β by Application
1.3.1 Global Recombinant Human Transforming Growth Factor-β Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Global Recombinant Human Transforming Growth Factor-β Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Transforming Growth Factor-β Revenue 2021–2032
1.4.2 Global Recombinant Human Transforming Growth Factor-β Sales 2021–2032
1.4.3 Global Recombinant Human Transforming Growth Factor-β Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Recombinant Human Transforming Growth Factor-β Market Competition by Manufacturers
2.1 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Manufacturers (2021–2026)
2.2 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Recombinant Human Transforming Growth Factor-β Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Recombinant Human Transforming Growth Factor-β, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Product Types and Applications
2.7 Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Date of Entry into the Industry
2.8 Global Recombinant Human Transforming Growth Factor-β Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Transforming Growth Factor-β Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Recombinant Human Transforming Growth Factor-β Players Market Share by Revenue
2.8.3 Global Recombinant Human Transforming Growth Factor-β Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Transforming Growth Factor-β Market Scenario by Region
3.1 Global Recombinant Human Transforming Growth Factor-β Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021–2032
3.2.1 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021–2026
3.2.2 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2027–2032
3.3 Global Recombinant Human Transforming Growth Factor-β Revenue by Region: 2021–2032
3.3.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Region: 2021–2026
3.3.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Region: 2027–2032
3.4 North America Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
3.4.1 North America Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Recombinant Human Transforming Growth Factor-β Sales by Country (2021–2032)
3.4.3 North America Recombinant Human Transforming Growth Factor-β Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2021–2032)
3.5.3 Europe Recombinant Human Transforming Growth Factor-β Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Transforming Growth Factor-β Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Region (2021–2032)
3.6.3 Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Recombinant Human Transforming Growth Factor-β Sales by Country (2021–2032)
3.7.3 Latin America Recombinant Human Transforming Growth Factor-β Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (2021–2032)
3.8.3 Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021–2032)
4.1.1 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021–2026)
4.1.2 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2027–2032)
4.1.3 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2021–2032)
4.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021–2032)
4.2.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021–2026)
4.2.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2027–2032)
4.2.3 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2021–2032)
4.3 Global Recombinant Human Transforming Growth Factor-β Price by Type (2021–2032)
5 Segment by Application
5.1 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021–2032)
5.1.1 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021–2026)
5.1.2 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2027–2032)
5.1.3 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2021–2032)
5.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021–2032)
5.2.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021–2026)
5.2.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2027–2032)
5.2.3 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2021–2032)
5.3 Global Recombinant Human Transforming Growth Factor-β Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Recombinant Human Transforming Growth Factor-β Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Abcam
6.2.1 Abcam Company Information
6.2.2 Abcam Description and Business Overview
6.2.3 Abcam Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Abcam Recombinant Human Transforming Growth Factor-β Product Portfolio
6.2.5 Abcam Recent Developments/Updates
6.3 Atlantis Bioscience
6.3.1 Atlantis Bioscience Company Information
6.3.2 Atlantis Bioscience Description and Business Overview
6.3.3 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
6.3.5 Atlantis Bioscience Recent Developments/Updates
6.4 Sigma-Aldrich
6.4.1 Sigma-Aldrich Company Information
6.4.2 Sigma-Aldrich Description and Business Overview
6.4.3 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product Portfolio
6.4.5 Sigma-Aldrich Recent Developments/Updates
6.5 MedChemExpress
6.5.1 MedChemExpress Company Information
6.5.2 MedChemExpress Description and Business Overview
6.5.3 MedChemExpress Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 MedChemExpress Recombinant Human Transforming Growth Factor-β Product Portfolio
6.5.5 MedChemExpress Recent Developments/Updates
6.6 Miltenyi Biotec
6.6.1 Miltenyi Biotec Company Information
6.6.2 Miltenyi Biotec Description and Business Overview
6.6.3 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product Portfolio
6.6.5 Miltenyi Biotec Recent Developments/Updates
6.7 Bio-Techne
6.7.1 Bio-Techne Company Information
6.7.2 Bio-Techne Description and Business Overview
6.7.3 Bio-Techne Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Bio-Techne Recombinant Human Transforming Growth Factor-β Product Portfolio
6.7.5 Bio-Techne Recent Developments/Updates
6.8 Proteintech
6.8.1 Proteintech Company Information
6.8.2 Proteintech Description and Business Overview
6.8.3 Proteintech Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Proteintech Recombinant Human Transforming Growth Factor-β Product Portfolio
6.8.5 Proteintech Recent Developments/Updates
6.9 Cell Guidance Systems
6.9.1 Cell Guidance Systems Company Information
6.9.2 Cell Guidance Systems Description and Business Overview
6.9.3 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product Portfolio
6.9.5 Cell Guidance Systems Recent Developments/Updates
6.10 Cell Signaling Technology
6.10.1 Cell Signaling Technology Company Information
6.10.2 Cell Signaling Technology Description and Business Overview
6.10.3 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.10.5 Cell Signaling Technology Recent Developments/Updates
6.11 Qkine
6.11.1 Qkine Company Information
6.11.2 Qkine Description and Business Overview
6.11.3 Qkine Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Qkine Recombinant Human Transforming Growth Factor-β Product Portfolio
6.11.5 Qkine Recent Developments/Updates
6.12 ACROBiosystems
6.12.1 ACROBiosystems Company Information
6.12.2 ACROBiosystems Description and Business Overview
6.12.3 ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 ACROBiosystems Recombinant Human Transforming Growth Factor-β Product Portfolio
6.12.5 ACROBiosystems Recent Developments/Updates
6.13 FUJIFILM Irvine Scientific
6.13.1 FUJIFILM Irvine Scientific Company Information
6.13.2 FUJIFILM Irvine Scientific Description and Business Overview
6.13.3 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
6.13.5 FUJIFILM Irvine Scientific Recent Developments/Updates
6.14 Croyez Bioscience
6.14.1 Croyez Bioscience Company Information
6.14.2 Croyez Bioscience Description and Business Overview
6.14.3 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
6.14.5 Croyez Bioscience Recent Developments/Updates
6.15 Beijing Sino Biological
6.15.1 Beijing Sino Biological Company Information
6.15.2 Beijing Sino Biological Description and Business Overview
6.15.3 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product Portfolio
6.15.5 Beijing Sino Biological Recent Developments/Updates
6.16 Abbkine Scientific
6.16.1 Abbkine Scientific Company Information
6.16.2 Abbkine Scientific Description and Business Overview
6.16.3 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
6.16.5 Abbkine Scientific Recent Developments/Updates
6.17 Yeasen Biotechnology (Shanghai)
6.17.1 Yeasen Biotechnology (Shanghai) Company Information
6.17.2 Yeasen Biotechnology (Shanghai) Description and Business Overview
6.17.3 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product Portfolio
6.17.5 Yeasen Biotechnology (Shanghai) Recent Developments/Updates
6.18 Dalian Meilun Biotechnology
6.18.1 Dalian Meilun Biotechnology Company Information
6.18.2 Dalian Meilun Biotechnology Description and Business Overview
6.18.3 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.18.5 Dalian Meilun Biotechnology Recent Developments/Updates
6.19 Shanghai Zhong Qiao Xin Zhou Biotechnology
6.19.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
6.19.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Description and Business Overview
6.19.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.19.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments/Updates
6.20 Suzhou Novoprotein Scientific
6.20.1 Suzhou Novoprotein Scientific Company Information
6.20.2 Suzhou Novoprotein Scientific Description and Business Overview
6.20.3 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
6.20.5 Suzhou Novoprotein Scientific Recent Developments/Updates
6.21 Nanjing Okay Biotechnology
6.21.1 Nanjing Okay Biotechnology Company Information
6.21.2 Nanjing Okay Biotechnology Description and Business Overview
6.21.3 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.21.5 Nanjing Okay Biotechnology Recent Developments/Updates
6.22 Cellverse
6.22.1 Cellverse Company Information
6.22.2 Cellverse Description and Business Overview
6.22.3 Cellverse Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Cellverse Recombinant Human Transforming Growth Factor-β Product Portfolio
6.22.5 Cellverse Recent Developments/Updates
6.23 Beijing T&L Biotechnology
6.23.1 Beijing T&L Biotechnology Company Information
6.23.2 Beijing T&L Biotechnology Description and Business Overview
6.23.3 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.23.5 Beijing T&L Biotechnology Recent Developments/Updates
6.24 EIAAB SCIENCE
6.24.1 EIAAB SCIENCE Company Information
6.24.2 EIAAB SCIENCE Description and Business Overview
6.24.3 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product Portfolio
6.24.5 EIAAB SCIENCE Recent Developments/Updates
6.25 Shanghai DiLab Biotechnology
6.25.1 Shanghai DiLab Biotechnology Company Information
6.25.2 Shanghai DiLab Biotechnology Description and Business Overview
6.25.3 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.25.5 Shanghai DiLab Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Transforming Growth Factor-β Industry Chain Analysis
7.2 Recombinant Human Transforming Growth Factor-β Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Transforming Growth Factor-β Production Mode & Process Analysis
7.4 Recombinant Human Transforming Growth Factor-β Sales and Marketing
7.4.1 Recombinant Human Transforming Growth Factor-β Sales Channels
7.4.2 Recombinant Human Transforming Growth Factor-β Distributors
7.5 Recombinant Human Transforming Growth Factor-β Customer Analysis
8 Recombinant Human Transforming Growth Factor-β Market Dynamics
8.1 Recombinant Human Transforming Growth Factor-β Industry Trends
8.2 Recombinant Human Transforming Growth Factor-β Market Drivers
8.3 Recombinant Human Transforming Growth Factor-β Market Challenges
8.4 Recombinant Human Transforming Growth Factor-β Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Thermo Fisher
Abcam
Atlantis Bioscience
Sigma-aldrich
MedChemexpress LLC
Miltenyi Biotec
Bio-Techne
Proteintech
Cell Guidance Systems
Cell Signaling Technology
Qkine
ACROBiosystems
FUJIFILM Irvine Scientific
Beijing Sino Biological
Abbkine Scientific
Yeasen Biotechnology (Shanghai)
Shanghai Zhong Qiao Xin Zhou Biotechnology
Nanjing Okay Biotechnology
Cellverse
Beijing T&L Biotechnology
EIAAB SCIENCE
Croyez Bioscience
Dalian Meilun Biotechnology
Suzhou Novoprotein Scientific
Shanghai DiLab Biotechnology
Beijing T&L Biotechnology
List of Tables
 Table 1. Global Recombinant Human Transforming Growth Factor-β Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Recombinant Human Transforming Growth Factor-β Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Recombinant Human Transforming Growth Factor-β Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Recombinant Human Transforming Growth Factor-β Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Recombinant Human Transforming Growth Factor-β Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Recombinant Human Transforming Growth Factor-β, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Product Types and Applications
 Table 12. Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Human Transforming Growth Factor-β Companies by Tier (Tier 1, Tier 2, Tier 3), based on Recombinant Human Transforming Growth Factor-β Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Human Transforming Growth Factor-β Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Recombinant Human Transforming Growth Factor-β Sales by Region (K Units), 2021–2026
 Table 18. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2021–2026)
 Table 19. Global Recombinant Human Transforming Growth Factor-β Sales by Region (K Units), 2027–2032
 Table 20. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2027–2032)
 Table 21. Global Recombinant Human Transforming Growth Factor-β Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2021–2026)
 Table 23. Global Recombinant Human Transforming Growth Factor-β Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2027–2032)
 Table 25. North America Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2021–2026
 Table 27. North America Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2027–2032
 Table 28. North America Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2021–2026
 Table 32. Europe Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2027–2032
 Table 33. Europe Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2021–2026
 Table 42. Latin America Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2027–2032
 Table 43. Latin America Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) by Type (2021–2026)
 Table 51. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) by Type (2027–2032)
 Table 52. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2021–2026)
 Table 53. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2027–2032)
 Table 54. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2021–2026)
 Table 57. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2027–2032)
 Table 58. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) by Application (2021–2026)
 Table 61. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) by Application (2027–2032)
 Table 62. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2021–2026)
 Table 63. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2027–2032)
 Table 64. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2021–2026)
 Table 67. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2027–2032)
 Table 68. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Application (2027–2032)
 Table 70. Thermo Fisher Company Information
 Table 71. Thermo Fisher Description and Business Overview
 Table 72. Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Thermo Fisher Recombinant Human Transforming Growth Factor-β Product
 Table 74. Thermo Fisher Recent Developments/Updates
 Table 75. Abcam Company Information
 Table 76. Abcam Description and Business Overview
 Table 77. Abcam Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Abcam Recombinant Human Transforming Growth Factor-β Product
 Table 79. Abcam Recent Developments/Updates
 Table 80. Atlantis Bioscience Company Information
 Table 81. Atlantis Bioscience Description and Business Overview
 Table 82. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product
 Table 84. Atlantis Bioscience Recent Developments/Updates
 Table 85. Sigma-Aldrich Company Information
 Table 86. Sigma-Aldrich Description and Business Overview
 Table 87. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product
 Table 89. Sigma-Aldrich Recent Developments/Updates
 Table 90. MedChemExpress Company Information
 Table 91. MedChemExpress Description and Business Overview
 Table 92. MedChemExpress Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. MedChemExpress Recombinant Human Transforming Growth Factor-β Product
 Table 94. MedChemExpress Recent Developments/Updates
 Table 95. Miltenyi Biotec Company Information
 Table 96. Miltenyi Biotec Description and Business Overview
 Table 97. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product
 Table 99. Miltenyi Biotec Recent Developments/Updates
 Table 100. Bio-Techne Company Information
 Table 101. Bio-Techne Description and Business Overview
 Table 102. Bio-Techne Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Bio-Techne Recombinant Human Transforming Growth Factor-β Product
 Table 104. Bio-Techne Recent Developments/Updates
 Table 105. Proteintech Company Information
 Table 106. Proteintech Description and Business Overview
 Table 107. Proteintech Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Proteintech Recombinant Human Transforming Growth Factor-β Product
 Table 109. Proteintech Recent Developments/Updates
 Table 110. Cell Guidance Systems Company Information
 Table 111. Cell Guidance Systems Description and Business Overview
 Table 112. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product
 Table 114. Cell Guidance Systems Recent Developments/Updates
 Table 115. Cell Signaling Technology Company Information
 Table 116. Cell Signaling Technology Description and Business Overview
 Table 117. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product
 Table 119. Cell Signaling Technology Recent Developments/Updates
 Table 120. Qkine Company Information
 Table 121. Qkine Description and Business Overview
 Table 122. Qkine Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Qkine Recombinant Human Transforming Growth Factor-β Product
 Table 124. Qkine Recent Developments/Updates
 Table 125. ACROBiosystems Company Information
 Table 126. ACROBiosystems Description and Business Overview
 Table 127. ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. ACROBiosystems Recombinant Human Transforming Growth Factor-β Product
 Table 129. ACROBiosystems Recent Developments/Updates
 Table 130. FUJIFILM Irvine Scientific Company Information
 Table 131. FUJIFILM Irvine Scientific Description and Business Overview
 Table 132. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product
 Table 134. FUJIFILM Irvine Scientific Recent Developments/Updates
 Table 135. Croyez Bioscience Company Information
 Table 136. Croyez Bioscience Description and Business Overview
 Table 137. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product
 Table 139. Croyez Bioscience Recent Developments/Updates
 Table 140. Beijing Sino Biological Company Information
 Table 141. Beijing Sino Biological Description and Business Overview
 Table 142. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product
 Table 144. Beijing Sino Biological Recent Developments/Updates
 Table 145. Abbkine Scientific Company Information
 Table 146. Abbkine Scientific Description and Business Overview
 Table 147. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product
 Table 149. Abbkine Scientific Recent Developments/Updates
 Table 150. Yeasen Biotechnology (Shanghai) Company Information
 Table 151. Yeasen Biotechnology (Shanghai) Description and Business Overview
 Table 152. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product
 Table 154. Yeasen Biotechnology (Shanghai) Recent Developments/Updates
 Table 155. Dalian Meilun Biotechnology Company Information
 Table 156. Dalian Meilun Biotechnology Description and Business Overview
 Table 157. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product
 Table 159. Dalian Meilun Biotechnology Recent Developments/Updates
 Table 160. Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
 Table 161. Shanghai Zhong Qiao Xin Zhou Biotechnology Description and Business Overview
 Table 162. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 163. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product
 Table 164. Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments/Updates
 Table 165. Suzhou Novoprotein Scientific Company Information
 Table 166. Suzhou Novoprotein Scientific Description and Business Overview
 Table 167. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 168. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product
 Table 169. Suzhou Novoprotein Scientific Recent Developments/Updates
 Table 170. Nanjing Okay Biotechnology Company Information
 Table 171. Nanjing Okay Biotechnology Description and Business Overview
 Table 172. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 173. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product
 Table 174. Nanjing Okay Biotechnology Recent Developments/Updates
 Table 175. Cellverse Company Information
 Table 176. Cellverse Description and Business Overview
 Table 177. Cellverse Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 178. Cellverse Recombinant Human Transforming Growth Factor-β Product
 Table 179. Cellverse Recent Developments/Updates
 Table 180. Beijing T&L Biotechnology Company Information
 Table 181. Beijing T&L Biotechnology Description and Business Overview
 Table 182. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 183. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product
 Table 184. Beijing T&L Biotechnology Recent Developments/Updates
 Table 185. EIAAB SCIENCE Company Information
 Table 186. EIAAB SCIENCE Description and Business Overview
 Table 187. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 188. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product
 Table 189. EIAAB SCIENCE Recent Developments/Updates
 Table 190. Shanghai DiLab Biotechnology Company Information
 Table 191. Shanghai DiLab Biotechnology Description and Business Overview
 Table 192. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 193. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product
 Table 194. Shanghai DiLab Biotechnology Recent Developments/Updates
 Table 195. Key Raw Materials Lists
 Table 196. Raw Materials Key Suppliers Lists
 Table 197. Recombinant Human Transforming Growth Factor-β Distributors List
 Table 198. Recombinant Human Transforming Growth Factor-β Customers List
 Table 199. Recombinant Human Transforming Growth Factor-β Market Trends
 Table 200. Recombinant Human Transforming Growth Factor-β Market Drivers
 Table 201. Recombinant Human Transforming Growth Factor-β Market Challenges
 Table 202. Recombinant Human Transforming Growth Factor-β Market Restraints
 Table 203. Research Programs/Design for This Report
 Table 204. Key Data Information from Secondary Sources
 Table 205. Key Data Information from Primary Sources
 Table 206. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Human Transforming Growth Factor-β
 Figure 2. Global Recombinant Human Transforming Growth Factor-β Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Recombinant Human Transforming Growth Factor-β Market Share by Type: 2025 & 2032
 Figure 4. TGF-β1 Product Picture
 Figure 5. TGF-β2 Product Picture
 Figure 6. TGF-β3 Product Picture
 Figure 7. Global Recombinant Human Transforming Growth Factor-β Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Recombinant Human Transforming Growth Factor-β Market Share by Application: 2025 & 2032
 Figure 9. Hospital
 Figure 10. Research Institute
 Figure 11. Others
 Figure 12. Global Recombinant Human Transforming Growth Factor-β Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Recombinant Human Transforming Growth Factor-β Market Size (US$ Million), 2021–2032
 Figure 14. Global Recombinant Human Transforming Growth Factor-β Sales (K Units), 2021–2032
 Figure 15. Global Recombinant Human Transforming Growth Factor-β Average Price (US$/Unit), 2021–2032
 Figure 16. Recombinant Human Transforming Growth Factor-β Report Years Considered
 Figure 17. Recombinant Human Transforming Growth Factor-β Sales Share by Manufacturers in 2025
 Figure 18. Global Recombinant Human Transforming Growth Factor-β Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Recombinant Human Transforming Growth Factor-β Players: Market Share by Revenue in Recombinant Human Transforming Growth Factor-β in 2025
 Figure 20. Recombinant Human Transforming Growth Factor-β Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Recombinant Human Transforming Growth Factor-β Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021–2032)
 Figure 23. North America Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021–2032)
 Figure 24. United States Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021–2032)
 Figure 27. Europe Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2021–2032)
 Figure 35. China Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Recombinant Human Transforming Growth Factor-β by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Recombinant Human Transforming Growth Factor-β by Type (2021–2032)
 Figure 55. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Recombinant Human Transforming Growth Factor-β by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Recombinant Human Transforming Growth Factor-β by Application (2021–2032)
 Figure 58. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Application (2021–2032)
 Figure 59. Recombinant Human Transforming Growth Factor-β Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Recombinant Human Basic Fibroblast Growth Factor Market Research Report 2024
Global Recombinant bFGF Market Research Report 2025
Global Recombinant Human BMP 2 Market Research Report 2024
Global Transforming Growth Factor Beta 1 Market Insights Forecast to 2030
Drugs Based on TGF β1 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Fibroblast Growth Factor Market Research Report 2024
Global Recombinant Bovine Basic Fibroblast Growth Factor rb bFGF Market Research Report 2025
Global Recombinant Humanized Collagen Type III Market Research Report 2024
Global Recombinant Human Fibroblast Growth Factor Kit Market Research Report 2024
Global Human Fibroblast Growth Factor Market Research Report 2024
Global Human Activin A Market Insights Forecast to 2030
Global Human Recombinant Growth Factors Market Research Report 2025
Global Recombinant Human Bone Morphogenetic Protein rhBMP Market Research Report 2024
Global Recombinant Human Growth Hormone Market Research Report 2025
Global Human Fibroblast Growth Factor 2 FGF2 Market Research Report 2024
Global Human Fibroblast Growth Factor Detection Kit Market Research Report 2025
Global Recombinant Growth Hormone Market Research Report 2024
Global rh EGF Topical Solution Market Research Report 2024
Global Fibroblast Growth Factor Kit Market Research Report 2024
Global Recombinant Growth Factors Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions